Cargando…
The 3D structure analysis of SARS-CoV S1 protein reveals a link to influenza virus neuraminidase and implications for drug and antibody discovery
The spike protein of SARS-associated coronavirus (SARS-CoV) is an important target for anti-SARS drug discovery. Its S1 domain is responsible for receptor binding and SARS-CoV entry into cells. In this study, we constructed a rational 3D model for S1 domain of SARS-CoV spike protein by fold recognit...
Autores principales: | Zhang, Xue Wu, Yap, Yee Leng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126208/ https://www.ncbi.nlm.nih.gov/pubmed/32287547 http://dx.doi.org/10.1016/j.theochem.2004.04.065 |
Ejemplares similares
-
Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
por: Gao, Jin, et al.
Publicado: (2016) -
Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design
por: Zhang, Xue Wu, et al.
Publicado: (2004) -
Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022) -
Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011) -
Management of Influenza Virus Infections with Neuraminidase Inhibitors: Detection, Incidence, and Implications of Drug Resistance
por: McKimm-Breschkin, Jennifer L.
Publicado: (2012)